CJC-1295 No-DAC Nasal Spray

Product Overview

CJC-1295 No-DAC Nasal Spray is an intranasal research formulation of the synthetic peptide CJC-1295 (without Drug Affinity Complex), supplied exclusively by Direct Anti Peptide for qualified laboratory and scientific research purposes. This preparation delivers the same growth hormone-releasing peptide backbone as conventional CJC-1295 No-DAC in a convenient, non-injectable spray format, making it a compelling subject of investigation for researchers studying peptide bioavailability, hormonal signalling pathways, and mucosal absorption dynamics. Each unit is manufactured to a minimum verified purity of ≥98%, ensuring consistent, reproducible experimental conditions across research protocols.

Peptide Structure & Amino Acid Sequence

CJC-1295 No-DAC is a 30-amino acid synthetic analogue of endogenous Growth Hormone-Releasing Hormone (GHRH). Unlike the DAC-containing variant, this version omits the Drug Affinity Complex, resulting in a shorter plasma half-life and a more pulsatile release profile — characteristics that make it particularly valuable for time-course and pharmacokinetic research studies. The peptide sequence mirrors the first 29 residues of native GHRH with strategic modifications to enhance stability against enzymatic degradation, a property of significant interest to researchers investigating peptide longevity in biological matrices.

Chemical & Physical Characteristics

• Peptide: CJC-1295 No-DAC (GHRH analogue, no Drug Affinity Complex)
• Format: Intranasal aqueous spray solution
• Available Sizes: 15ml (contains 2mg peptide) | 30ml (contains 4mg peptide)
• Purity: ≥98% by HPLC
• Appearance: Clear to slightly opalescent aqueous solution
• Storage Temperature: 2–8°C (refrigerated); protect from light and freeze-thaw cycles
• Solubility: Water-soluble; formulated in a buffered aqueous carrier suitable for mucosal delivery research

Purity & Analytical Verification (HPLC & MS)

Every batch of CJC-1295 No-DAC Nasal Spray supplied by Direct Anti Peptide undergoes rigorous analytical testing prior to release. High-Performance Liquid Chromatography (HPLC) is employed to confirm peptide purity at ≥98%, while Mass Spectrometry (MS) verifies molecular identity and confirms the absence of truncated sequences, oxidative by-products, or residual synthesis impurities. Researchers can rely on this dual-verification process to ensure experimental integrity and data reproducibility across independent studies.

Quality Control & Lyophilization Integrity

While this product is supplied as a ready-to-use nasal spray solution rather than a lyophilised powder, the same rigorous quality control standards applied to our lyophilised peptide range are maintained throughout the liquid formulation process. Sterile filtration, controlled fill volumes, and sealed tamper-evident packaging are employed to preserve peptide integrity from manufacture through to the end user. Batch-specific Certificates of Analysis (CoA) are available upon request for all orders placed through Direct Anti Peptide.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for use by trained research professionals operating within appropriately equipped laboratory environments. Standard laboratory personal protective equipment (PPE) — including gloves, eye protection, and lab coat — should be worn when handling this formulation. Avoid contact with eyes, skin, and mucous membranes outside of controlled experimental conditions. Do not ingest. Store away from children and non-research personnel. Dispose of unused material in accordance with local institutional and regulatory waste disposal guidelines.

Reconstitution, Packaging & Storage

CJC-1295 No-DAC Nasal Spray is supplied as a pre-formulated aqueous solution in a sealed nasal spray bottle — no reconstitution is required. Upon receipt, store immediately at 2–8°C in a refrigerator. Protect from direct light exposure and avoid repeated freeze-thaw cycling, which may compromise peptide stability. Do not use beyond the expiry date printed on the label. Packaging is designed to maintain product integrity during transit and storage, with tamper-evident seals to assure researchers of product authenticity.

Intended Research Use & Market Positioning

CJC-1295 No-DAC Nasal Spray is positioned as a premium research tool for investigators studying growth hormone secretagogue activity, intranasal peptide pharmacokinetics, neuroendocrine signalling, and metabolic regulation in preclinical research models. The intranasal delivery format presents a scientifically interesting alternative to injectable administration routes, enabling studies on mucosal membrane absorption, systemic bioavailability, and onset-of-action dynamics. Direct Anti Peptide supplies this compound to academic institutions, pharmaceutical research organisations, and independent laboratories seeking best-price, high-purity research peptides available for sale online.

Ordering, Availability & Fulfillment

Direct Anti Peptide offers CJC-1295 No-DAC Nasal Spray for sale in two sizes — 15ml and 30ml — with secure online ordering and prompt dispatch. All orders are processed efficiently with discreet, research-compliant packaging. Buy online today through our secure checkout to take advantage of competitive pricing, reliable stock availability, and dedicated customer support for research professionals. Bulk enquiries and institutional purchase orders are welcomed — contact our team directly for volume pricing.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 No-DAC Nasal Spray is sold exclusively as a laboratory research compound. It has not been evaluated or approved by any regulatory authority for therapeutic, diagnostic, or preventative use in humans or animals. Direct Anti Peptide assumes no liability for misuse, improper handling, or use outside of a controlled research environment. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the procurement and use of research peptides.